Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza) for adult patients with a rare condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback